Clinical Pharmacology & Therapeutics · 1983 · 18 citations · 16 references
PharmacyPharmacokineticsPharmacologyDialysisDrug ClearanceRenal PharmacokineticsDialysis PharmacotherapyPeritoneal DialysisPharmacokinetics In Renal ImpairmentRenal ClearanceRenal Drug ClearanceClinical Pharmacology EvidenceDrug Clearance During Peritoneal DialysisEliminationElimination MechanismsPeritoneal Dialysis DosingPeritoneal Dialysis PharmacokineticsPharmacokinetics In DialysisRenal Plasma Clearance
Moxalactam kinetics in renal failure were followed in eight patients undergoing chronic ambulatory peritoneal dialysis (CAPD) after a single 1-gm IV infusion. Elimination t 1/2 was 16.7 +/- 2.1 hr, with an apparent volume of distribution of 0.21 +/- 0.01 l/kg and plasma clearance of 10.6 +/- 2 ml/min. In 24 hr, 17.4 +/- 3.1% of the dose was present in the dialysis fluids, and 14.6 +/- 5.7% was excreted in the urine. Renal and peritoneal clearance values were thus 2.3 +/- 1.1 and 2.7 +/- 0.5 ml/min. Peritoneal concentrations were high (22.7 +/- 2.2 micrograms/ml). A recommended dosage schedule is proposed on the basis of moxalactam kinetics during CAPD.
16
Michael Barza, Francis P. Tally, N V Jacobus et al. · Antimicrobial Agents and Chemotherapy · 1979 · 93 citations · Full text
Robert J. Fass · Antimicrobial Agents and Chemotherapy · 1979 · 65 citations · Full text